ELIFE Holdings Limited (ELIFE HLDGS) disclosed that on 29 April 2026 it allotted 271.22 million new ordinary shares under a specific mandate, completing a placing agreement first announced on 9 January 2026 and amended on 12 January 2026.

The new shares were issued at HKD 0.102 each, implying gross proceeds of about HKD 27.66 million. Prior to the transaction, the company had 1.36 billion shares in issue; the placement represents 20.00% of that number.

Following the allotment, ELIFE HLDGS’ issued share capital increased to 1.63 billion shares. The newly issued shares account for approximately 16.67% of the enlarged share base.

No treasury shares were held, sold, or repurchased during the period. The board confirmed that the issuance complied with all applicable Hong Kong listing rules and regulatory requirements.